Specialty Pharmaceutical Company dedicated to patients living with chronic conditions

Filing date Description Form Filing Group Filer View

Post-effective amendment to an S-8 filing

S-8 POS
Registration Statements
0001193125-19-205457.pdf 0001193125-19-205457.rtf 0001193125-19-205457.xls View HTML

Post-effective amendment to an S-8 filing

S-8 POS
Registration Statements
0001193125-19-205467.pdf 0001193125-19-205467.rtf 0001193125-19-205467.xls View HTML

Post-effective amendment to an S-8 filing

S-8 POS
Registration Statements
0001193125-19-205477.pdf 0001193125-19-205477.rtf 0001193125-19-205477.xls View HTML

Securities offered to employees pursuant to employee benefit plans

S-8
Registration Statements
0001193125-19-205575.pdf 0001193125-19-205575.rtf 0001193125-19-205575.xls View HTML

Simplified registration form

S-3
Registration Statements
0001193125-19-205600.pdf 0001193125-19-205600.rtf 0001193125-19-205600.xls View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-19-202620.pdf 0001193125-19-202620.rtf 0001193125-19-202620.xls View HTML

Additional proxy soliciting materials - definitive

DEFA14A
Proxy Filings
0001193125-19-195674.pdf 0001193125-19-195674.rtf 0001193125-19-195674.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0000899243-19-019205.pdf 0000899243-19-019205.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Sirgo Mark A 0000899243-19-018444.pdf 0000899243-19-018444.rtf View HTML

Official notification to shareholders of matters to be brought to a vote ("Proxy")

DEF 14A
Proxy Filings
0001193125-19-174854.pdf 0001193125-19-174854.rtf 0001193125-19-174854.xls View HTML

Copyright Morningstar

BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Thank you. We will get back to you soon